The Acute Intermittent Porphyria Market will grow at highest pace owing to rising prevalence of rare genetic diseases

Acute Intermittent Porphyria (AIP) is a rare genetic disease characterized by attacks of severe abdominal pain, vomiting, and neurological abnormalities. The condition results from a deficiency in the enzyme porphobilinogen deaminase (PBGD). Symptoms include severe abdominal pain, nausea or vomiting, constipation, and other neurological symptoms su

read more



The Rising Acid Sphingomyelinase Deficiency (ASMD) Market Set to Grow at Highest Pace Owing to Increasing Research and Development Activities

ASMD is a rare, inherited genetic disorder in which kids are born deficient in an enzyme called acid sphingomyelinase (ASM). This enzyme plays a key role in breaking down a fatty substance called sphingomyelin. A deficiency in this enzyme results in the abnormal accumulation of sphingomyelin in various tissues, especially in cells of the liver, spl

read more